Cargando…
Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia?
As the current COVID-19 pandemic develops and epidemiological data reveals differences in geographical spread as well as risk factors for developing a severe course of illness, hypotheses regarding possible underlying mechanisms need to be developed and tested. In our hypothesis, we explore the rati...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467063/ https://www.ncbi.nlm.nih.gov/pubmed/33254541 http://dx.doi.org/10.1016/j.mehy.2020.110234 |
_version_ | 1783577940183744512 |
---|---|
author | Karst, Matthias Hollenhorst, Josef Achenbach, Johannes |
author_facet | Karst, Matthias Hollenhorst, Josef Achenbach, Johannes |
author_sort | Karst, Matthias |
collection | PubMed |
description | As the current COVID-19 pandemic develops and epidemiological data reveals differences in geographical spread as well as risk factors for developing a severe course of illness, hypotheses regarding possible underlying mechanisms need to be developed and tested. In our hypothesis, we explore the rational for a role of MTHFR polymorphism C677T as a possible explanation for differences in geographical and gender distribution in disease severity. We also discuss the role of the resulting hyper-homocysteinemia, its interaction with the C677T polymorphism and its influence on immune state as well as risk factors for severe disease. Finally, we consider possible dietary ways to influence the underlying pathomechanisms prophylactically and supportively. |
format | Online Article Text |
id | pubmed-7467063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74670632020-09-03 Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? Karst, Matthias Hollenhorst, Josef Achenbach, Johannes Med Hypotheses Article As the current COVID-19 pandemic develops and epidemiological data reveals differences in geographical spread as well as risk factors for developing a severe course of illness, hypotheses regarding possible underlying mechanisms need to be developed and tested. In our hypothesis, we explore the rational for a role of MTHFR polymorphism C677T as a possible explanation for differences in geographical and gender distribution in disease severity. We also discuss the role of the resulting hyper-homocysteinemia, its interaction with the C677T polymorphism and its influence on immune state as well as risk factors for severe disease. Finally, we consider possible dietary ways to influence the underlying pathomechanisms prophylactically and supportively. Elsevier Ltd. 2020-11 2020-09-02 /pmc/articles/PMC7467063/ /pubmed/33254541 http://dx.doi.org/10.1016/j.mehy.2020.110234 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Karst, Matthias Hollenhorst, Josef Achenbach, Johannes Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
title | Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
title_full | Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
title_fullStr | Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
title_full_unstemmed | Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
title_short | Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
title_sort | life-threatening course in coronavirus disease 2019 (covid-19): is there a link to methylenetetrahydrofolic acid reductase (mthfr) polymorphism and hyperhomocysteinemia? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467063/ https://www.ncbi.nlm.nih.gov/pubmed/33254541 http://dx.doi.org/10.1016/j.mehy.2020.110234 |
work_keys_str_mv | AT karstmatthias lifethreateningcourseincoronavirusdisease2019covid19istherealinktomethylenetetrahydrofolicacidreductasemthfrpolymorphismandhyperhomocysteinemia AT hollenhorstjosef lifethreateningcourseincoronavirusdisease2019covid19istherealinktomethylenetetrahydrofolicacidreductasemthfrpolymorphismandhyperhomocysteinemia AT achenbachjohannes lifethreateningcourseincoronavirusdisease2019covid19istherealinktomethylenetetrahydrofolicacidreductasemthfrpolymorphismandhyperhomocysteinemia |